| Name | Title | Contact Details |
|---|
OMi Cranes provides one of the few 100% turnkey solutions for your overhead lifting needs. We are a true overhead crane manufacturer, not just an assembler of others components. Whether providing a standard offering or completely customized solution, we know what works to fit your needs and budget. With over 30 years of industry experience, we provide the reliability for customers depend on. OMi Crane Systems, Inc. is a active member of Crane Manufacturers Association of America (CMAA). CMAA is an affiliate of the United States Division of Material Handling Industry (MHI). OMi Crane Systems, Inc. builds cranes to comply with OSHA standards, as well as CMAA and NEC specifications.
The National Basketball Association (NBA) is a professional sports league in North America, established in 1946. Headquartered in New York City, the NBA is one of the four major professional sports leagues in the United States and Canada. It is known for its competitive basketball games, iconic players, and extensive global reach. The NBA organizes regular season games, playoffs, and the NBA Finals, attracting millions of viewers worldwide. It also oversees the NBA G League, which serves as a developmental platform for players and staff, and runs Jr. NBA programs to promote basketball among youth. The league is committed to community outreach through NBA Cares, focusing on building facilities and supporting education and health initiatives. With a strong presence in over 200 countries, the NBA utilizes advanced technology and media platforms to engage fans and enhance their experience.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
At OPTIMUM, an architecture, furniture, and technology (A/F/T) products collective, were not defined by size or the number of product lines but by our unique design-thinking approach. We believe in solving workplace challenges by optimizing the integration of architecture, furniture, and technology to create seamless experiences for those who design, plan, deliver, and occupy spaces. What sets us apart is our focus on offering aesthetically appealing, high-performance products that balance design and cost-efficiency, along with our partnerships with flexible manufacturers who can customize solutions to meet specific needs. Success isnt about individual pieces; its about the synergy that happens when people, elements, and solutions come together, resulting in outcomes far greater than the sum of their parts. This philosophy drives everything we do at OPTIMUM as we enhance the environments where we live, work, learn, and heal.